DocGo Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
In the fourth quarter of 2023, other than as disclosed below, none of our directors or officers (as defined in Rule 16a-1 under the Exchange Act)adopted, modified orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 105b-1 trading arrangement” (as those terms are defined in Item 408 of Regulation S-K).
| Name | Title | Date Plan Adopted / Terminated | Original Duration of Plan | Shares to be Purchased or Sold | Intended to Satisfy Rule 10b5-1(c)? |
|---|---|---|---|---|---|
| Lee Bienstock | Chief Executive Officer | Adopted May 17, 2023 and terminated November 10, 2023 | August 16, 2023 to July 19, 2024 | Sell 20,000 | Yes |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.